Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Last trade$29.97
Day change-$0.175 (-0.58%)
Day range$29.75 – $30.17
Volume678,938
Market cap$29.47B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for PHG.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for PHG.
Recent news
Company coverage with links to the original publishers.
Koninklijke Philips reported strong equipment order intake growth of 8% with Diagnosis & Treatment orders surging nearly 20%, and Personal Health sales rising 8%. However, ultrasound manufacturing delays, China's pricing pressure from centralized procurement, and inflation concerns pose significant risks to profitability and growth trajectory. The company maintains a Zacks Rank #3 (Hold) rating.
Philips reported 8% equipment order intake growth in Q3 2026, driven by hospitals consolidating vendors and prioritizing clinical value over price. The company is scaling its Enterprise Monitoring as a Service subscription model with revenues nearly doubling year-over-year, while productivity savings of EUR 170 million in Q3 are offsetting inflation pressures. Management remains on track for mid-single-digit comparable sales growth CAGR through 2028 and mid-teen adjusted EBITA margins by 2028.
The global medical imaging workstations market is estimated at USD 6.20 billion in 2026 and projected to reach USD 12.55 billion by 2036, expanding at a CAGR of 7.3%. Growth is driven by rising chronic disease prevalence, digital imaging infrastructure investments, AI integration, and enterprise imaging adoption. Key challenges include high costs, cybersecurity risks, and radiologist shortages, while opportunities exist in cloud-based solutions and emerging markets.
Koninklijke Philips announced the U.S. commercial launch of its HyperVue Integrated System, combining advanced coronary imaging (DeepOCT+NIRS) with AI-driven physiology assessment (X1-FFR) in a permanently installed cath lab configuration. The system aims to streamline percutaneous coronary intervention procedures and strengthen Philips' position in the interventional cardiology market, which is projected to grow at 7.3% CAGR through 2033.
Royal Philips announced U.S. commercial availability of the HyperVue Integrated System, a fixed single-room configuration combining DeepOCT+NIRS imaging and X1-FFR physiology assessment for coronary interventions. The system is designed to streamline cathlab workflows by eliminating setup steps and keeping advanced imaging and physiology tools readily available. Philips will showcase this alongside its broader portfolio including IntraSight Plus at TCT 2026.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
May 13, 2026
$0.99
Jun 3, 2026
recurring
May 13, 2025
$0.9327
Jun 6, 2025
recurring
May 12, 2022
$0.781
Jun 8, 2022
recurring
May 10, 2021
$0.8541
Jun 9, 2021
recurring
May 13, 2019
$0.764
Jun 13, 2019
recurring
Stock splits
Historical share-structure events and their execution dates.